Literature DB >> 10862087

Identification of 5 novel mutations in the AGXT gene.

O Basmaison1, M O Rolland, P Cochat, D Bozon.   

Abstract

In order to identify additional genotypes in primary hyperoxaluria type 1, we sequenced the AGXT genes of 9 patients. We report 5 new mutations. Three are splice-site mutations situated at the end of intron 4 and 8 (647-1G>A, 969-1G>C, 969-3C>G), one is a missense mutation in exon 5 (D183N), and one is a short duplication in exon 2 (349ins7). Their consequence is always a lack of enzymatic activity of the Alanine-Glyoxylate Aminotransferase (AGT); for 4 of them, we were able to deduce that they were associated to the absence of AGT protein. These mutations are rare, as they have been found on one allele in our study (except 969-3C>G present in 2 unrelated families), and have not been previously reported.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10862087     DOI: 10.1002/1098-1004(200006)15:6<577::AID-HUMU9>3.0.CO;2-#

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

Review 1.  Primary hyperoxaluria type 1: still challenging!

Authors:  Pierre Cochat; Aurélia Liutkus; Sonia Fargue; Odile Basmaison; Bruno Ranchin; Marie-Odile Rolland
Journal:  Pediatr Nephrol       Date:  2006-06-30       Impact factor: 3.714

2.  Primary hyperoxaluria in a compound heterozygote infant.

Authors:  Juan Mayordomo-Colunga; Debora Riverol; Eduardo Salido; Fernando Santos
Journal:  World J Pediatr       Date:  2010-06-12       Impact factor: 2.764

Review 3.  Oxalate crystal deposition disease.

Authors:  Irama Maldonado; Vineet Prasad; Antonio J Reginato
Journal:  Curr Rheumatol Rep       Date:  2002-06       Impact factor: 4.592

4.  Importance of Assessing Compliance with Conservative Treatment of Primary Hyperoxaluria Type 1: A Case Report of a Patient with I244T/c.969-3C>G Mutation.

Authors:  Paloma Gutiérrez Medina; Laura Espinosa Román
Journal:  Perm J       Date:  2019-12-30

5.  Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.

Authors:  Elisa Oppici; Riccardo Montioli; Antonio Lorenzetto; Silvia Bianconi; Carla Borri Voltattorni; Barbara Cellini
Journal:  Mol Genet Metab       Date:  2011-10-05       Impact factor: 4.797

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.